January 2024 FDA Recall Drug by Amneal Pharmaceuticals Of New York, Llc
D-0319-2024 - Failed Impurities/Degradation Specifications

This Class II drug recall was voluntarily initiated by Amneal Pharmaceuticals Of New York, Llc on January 15, 2024 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0319-2024

Reason for Recall
Failed Impurities/Degradation Specifications: Out of specification for unknown impurity.
Initiated
01-15-2024
Reported
02-14-2024
Quantity
858 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Amneal Pharmaceuticals of New York, LLC
Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd, Oral Solid Dosage Unit, Ahmedabad 382213, India, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 60219-1502-01

Batch or Lot Expiration Information

Lot# AM221153, Exp. date 06/30/2024; AM230497, Exp. date 02/29/2025